Agios Pharmaceuticals, Inc. (AGIO)
28.15
+0.23
(+0.82%)
USD |
NASDAQ |
Mar 20, 13:52
Agios Pharmaceuticals Total Assets (Quarterly) : 1.297B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 59.02B |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
| CorMedix, Inc. | 877.63M |
| Enanta Pharmaceuticals, Inc. | 329.50M |
| Karyopharm Therapeutics, Inc. | 117.46M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 104.11M |
| Shareholders Equity (Quarterly) | 1.193B |
| Debt to Equity Ratio | 0.0337 |
| Current Ratio | 11.46 |
| Net Debt Paydown Yield | 0.26% |